SIMILAR PATTERNS OF AMINO ACIDS FOR 4A9J_A_TYLA1188_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ciy CRYIA(A)

(Bacillus
thuringiensis)
PF00555
(Endotoxin_M)
PF03944
(Endotoxin_C)
PF03945
(Endotoxin_N)
4 VAL A 160
LEU A 148
LEU A 157
ILE A  97
None
0.93A 4a9jA-1ciyA:
0.7
4a9jA-1ciyA:
13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ddg SULFITE REDUCTASE
(NADPH) FLAVOPROTEIN
ALPHA-COMPONENT


(Escherichia
coli)
PF00175
(NAD_binding_1)
PF00667
(FAD_binding_1)
4 VAL A 437
LEU A 268
LEU A 263
ILE A 390
None
0.89A 4a9jA-1ddgA:
0.0
4a9jA-1ddgA:
16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fps FARNESYL DIPHOSPHATE
SYNTHASE


(Gallus gallus)
PF00348
(polyprenyl_synt)
4 VAL A 285
LEU A 300
LEU A 199
ASN A 279
None
0.96A 4a9jA-1fpsA:
0.6
4a9jA-1fpsA:
17.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g61 TRANSLATION
INITIATION FACTOR 6


(Methanocaldococcus
jannaschii)
PF01912
(eIF-6)
4 VAL A2040
LEU A2028
LEU A2032
ILE A2015
None
0.96A 4a9jA-1g61A:
undetectable
4a9jA-1g61A:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kcz BETA-METHYLASPARTASE

(Clostridium
tetanomorphum)
PF05034
(MAAL_N)
PF07476
(MAAL_C)
4 VAL A 239
LEU A 211
LEU A 204
ILE A 258
None
0.97A 4a9jA-1kczA:
0.3
4a9jA-1kczA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kkr 3-METHYLASPARTATE
AMMONIA-LYASE


(Citrobacter
amalonaticus)
PF05034
(MAAL_N)
PF07476
(MAAL_C)
4 VAL A 239
LEU A 211
LEU A 204
ILE A 258
None
0.95A 4a9jA-1kkrA:
undetectable
4a9jA-1kkrA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lns X-PROLYL DIPEPTIDYL
AMINOPEPTIDASE


(Lactococcus
lactis)
PF02129
(Peptidase_S15)
PF08530
(PepX_C)
PF09168
(PepX_N)
4 VAL A 533
LEU A 493
LEU A 535
ASN A 614
None
0.83A 4a9jA-1lnsA:
0.0
4a9jA-1lnsA:
10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1no5 HYPOTHETICAL PROTEIN
HI0073


(Haemophilus
influenzae)
PF01909
(NTP_transf_2)
4 VAL A  78
LEU A  49
LEU A  80
ILE A  20
None
0.96A 4a9jA-1no5A:
undetectable
4a9jA-1no5A:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qze UV EXCISION REPAIR
PROTEIN RAD23
HOMOLOG A


(Homo sapiens)
PF00240
(ubiquitin)
PF00627
(UBA)
PF09280
(XPC-binding)
4 VAL A  25
LEU A  48
LEU A  55
ILE A   5
None
0.98A 4a9jA-1qzeA:
0.3
4a9jA-1qzeA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s3i 10-FORMYLTETRAHYDROF
OLATE DEHYDROGENASE


(Rattus
norvegicus)
PF00551
(Formyl_trans_N)
PF02911
(Formyl_trans_C)
4 VAL A 289
LEU A 279
LEU A 287
ILE A 211
None
0.93A 4a9jA-1s3iA:
undetectable
4a9jA-1s3iA:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xnt PROTEIN (DNA-REPAIR
PROTEIN XRCC1)


(Homo sapiens)
PF01834
(XRCC1_N)
4 VAL A 128
LEU A  47
LEU A   6
ILE A  60
None
0.94A 4a9jA-1xntA:
undetectable
4a9jA-1xntA:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zup HYPOTHETICAL PROTEIN
TM1739


(Thermotoga
maritima)
PF09376
(NurA)
4 VAL A 155
LEU A 253
LEU A 233
ILE A 273
None
0.97A 4a9jA-1zupA:
undetectable
4a9jA-1zupA:
18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aa4 PUTATIVE
N-ACETYLMANNOSAMINE
KINASE


(Escherichia
coli)
PF00480
(ROK)
4 VAL A 253
LEU A 268
LEU A 250
ILE A 127
None
0.88A 4a9jA-2aa4A:
undetectable
4a9jA-2aa4A:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aaz THYMIDYLATE SYNTHASE

(Cryptococcus
neoformans)
PF00303
(Thymidylat_synt)
4 VAL A 302
LEU A 280
LEU A  63
ILE A  77
None
0.82A 4a9jA-2aazA:
undetectable
4a9jA-2aazA:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cb1 O-ACETYL HOMOSERINE
SULFHYDRYLASE


(Thermus
thermophilus)
PF01053
(Cys_Met_Meta_PP)
4 VAL A 389
LEU A 333
LEU A 335
ILE A 348
None
0.95A 4a9jA-2cb1A:
undetectable
4a9jA-2cb1A:
15.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dvr BROMODOMAIN-CONTAINI
NG PROTEIN 2


(Homo sapiens)
PF00439
(Bromodomain)
5 VAL A  37
LEU A  42
LEU A  44
ASN A  90
ILE A  96
None
0.33A 4a9jA-2dvrA:
22.7
4a9jA-2dvrA:
82.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e0z VIRUS-LIKE PARTICLE

(Pyrococcus
furiosus)
PF04454
(Linocin_M18)
4 VAL A 204
LEU A 130
LEU A 134
ILE A 294
None
0.94A 4a9jA-2e0zA:
undetectable
4a9jA-2e0zA:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
4 VAL A 169
LEU A 179
LEU A 184
ILE A 231
None
0.95A 4a9jA-2ewnA:
undetectable
4a9jA-2ewnA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gv8 MONOOXYGENASE

(Schizosaccharomyces
pombe)
PF00743
(FMO-like)
PF13450
(NAD_binding_8)
4 VAL A 316
LEU A 336
ASN A 173
ILE A 171
None
0.94A 4a9jA-2gv8A:
undetectable
4a9jA-2gv8A:
15.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kzr UBIQUITIN
THIOESTERASE OTU1


(Mus musculus)
no annotation 4 VAL A   3
LEU A  17
LEU A  61
ILE A  30
None
0.91A 4a9jA-2kzrA:
undetectable
4a9jA-2kzrA:
19.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2l5e BROMODOMAIN-CONTAINI
NG PROTEIN 3


(Mus musculus)
PF00439
(Bromodomain)
4 LEU A  68
LEU A  70
ASN A 116
ILE A 122
None
0.88A 4a9jA-2l5eA:
17.0
4a9jA-2l5eA:
77.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ld7 HISTONE DEACETYLASE
COMPLEX SUBUNIT
SAP30
PAIRED AMPHIPATHIC
HELIX PROTEIN SIN3A


(Mus musculus)
PF02671
(PAH)
PF13867
(SAP30_Sin3_bdg)
4 VAL A 182
LEU A 150
LEU A 153
ILE B 490
None
0.94A 4a9jA-2ld7A:
undetectable
4a9jA-2ld7A:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ma9 TRANSCRIPTION
ELONGATION FACTOR B
POLYPEPTIDE 1
VIRION INFECTIVITY
FACTOR


(Homo sapiens;
Human
immunodeficiency
virus 1)
PF00559
(Vif)
PF03931
(Skp1_POZ)
4 VAL C  55
LEU C  85
LEU A   8
ILE C  47
None
0.96A 4a9jA-2ma9C:
undetectable
4a9jA-2ma9C:
23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mbg RALA-BINDING PROTEIN
1


(Homo sapiens)
PF00620
(RhoGAP)
4 VAL A 350
LEU A 278
LEU A 279
ILE A 322
None
0.59A 4a9jA-2mbgA:
undetectable
4a9jA-2mbgA:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mlb REDESIGNED UBIQUITIN

(synthetic
construct)
PF00240
(ubiquitin)
4 VAL A  18
LEU A  27
LEU A  57
ILE A  68
None
0.78A 4a9jA-2mlbA:
undetectable
4a9jA-2mlbA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o6q VARIABLE LYMPHOCYTE
RECEPTOR A


(Eptatretus
burgeri)
PF13855
(LRR_8)
4 VAL A 114
LEU A  95
LEU A 119
ILE A 102
None
0.97A 4a9jA-2o6qA:
undetectable
4a9jA-2o6qA:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2owo DNA LIGASE

(Escherichia
coli)
PF01653
(DNA_ligase_aden)
PF03119
(DNA_ligase_ZBD)
PF03120
(DNA_ligase_OB)
PF12826
(HHH_2)
PF14520
(HHH_5)
4 VAL A 444
LEU A 474
LEU A 500
ILE A 458
None
0.81A 4a9jA-2owoA:
undetectable
4a9jA-2owoA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p2s PUTATIVE
OXIDOREDUCTASE


(Pectobacterium
atrosepticum)
PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C)
4 VAL A 108
LEU A 105
LEU A  99
ILE A 317
None
0.97A 4a9jA-2p2sA:
undetectable
4a9jA-2p2sA:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qgi ATP SYNTHASE
SUBUNITS REGION ORF
6


(Rhodobacter
blasticus)
no annotation 4 VAL A  85
LEU A 200
LEU A  87
ILE A  79
None
0.97A 4a9jA-2qgiA:
undetectable
4a9jA-2qgiA:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qtz METHIONINE SYNTHASE
REDUCTASE


(Homo sapiens)
PF00175
(NAD_binding_1)
PF00667
(FAD_binding_1)
4 VAL A 469
LEU A 295
LEU A 284
ILE A 553
None
0.91A 4a9jA-2qtzA:
undetectable
4a9jA-2qtzA:
14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vgq SUGAR ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN,MITOCHONDRIA
L
ANTIVIRAL-SIGNALING
PROTEIN


(Escherichia
coli;
Homo sapiens)
PF13416
(SBP_bac_8)
PF16739
(CARD_2)
4 VAL A 391
LEU A 453
LEU A 445
ILE A 381
None
0.65A 4a9jA-2vgqA:
undetectable
4a9jA-2vgqA:
16.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wp1 BROMODOMAIN
TESTIS-SPECIFIC
PROTEIN


(Mus musculus)
PF00439
(Bromodomain)
4 VAL A 298
LEU A 303
LEU A 305
ASN A 351
None
0.41A 4a9jA-2wp1A:
18.2
4a9jA-2wp1A:
35.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yb5 PUTATIVE FUSIDIC
ACID RESISTANCE
PROTEIN


(Staphylococcus
aureus)
PF07299
(EF-G-binding_N)
PF16571
(FBP_C)
4 VAL A  12
LEU A  74
LEU A  77
ILE A  60
None
0.87A 4a9jA-2yb5A:
undetectable
4a9jA-2yb5A:
22.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2yek BROMODOMAIN-CONTAINI
NG PROTEIN 2


(Homo sapiens)
PF00439
(Bromodomain)
5 VAL A 103
LEU A 108
LEU A 110
ASN A 156
ILE A 162
EAM  A1188 (-4.4A)
EAM  A1188 ( 3.8A)
EAM  A1188 (-4.5A)
EAM  A1188 (-3.2A)
EAM  A1188 (-3.8A)
0.40A 4a9jA-2yekA:
23.3
4a9jA-2yekA:
99.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cdk SUCCINYL-COA:3-KETOA
CID-COENZYME A
TRANSFERASE SUBUNIT
A


(Bacillus
subtilis)
PF01144
(CoA_trans)
4 VAL A  51
LEU A  63
LEU A  66
ILE A 155
None
0.90A 4a9jA-3cdkA:
undetectable
4a9jA-3cdkA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ctz XAA-PRO
AMINOPEPTIDASE 1


(Homo sapiens)
PF00557
(Peptidase_M24)
PF01321
(Creatinase_N)
PF16188
(Peptidase_M24_C)
PF16189
(Creatinase_N_2)
4 VAL A 247
LEU A 251
LEU A 253
ILE A 237
None
0.73A 4a9jA-3ctzA:
undetectable
4a9jA-3ctzA:
13.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
4 VAL A1265
LEU A1104
LEU A1100
ILE A1136
None
0.94A 4a9jA-3dlsA:
undetectable
4a9jA-3dlsA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dpt RAB FAMILY PROTEIN

(Chlorobaculum
tepidum)
PF16095
(COR)
4 VAL A 695
LEU A 673
LEU A 676
ILE A 657
None
0.96A 4a9jA-3dptA:
undetectable
4a9jA-3dptA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dpu RAB FAMILY PROTEIN

(Chlorobaculum
tepidum)
PF08477
(Roc)
PF16095
(COR)
4 VAL A 695
LEU A 673
LEU A 676
ILE A 657
None
0.97A 4a9jA-3dpuA:
undetectable
4a9jA-3dpuA:
13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e4w PUTATIVE
UNCHARACTERIZED
PROTEIN


(Mycobacterium
avium)
PF00199
(Catalase)
4 VAL A 219
LEU A 214
LEU A 210
ILE A  62
None
0.97A 4a9jA-3e4wA:
undetectable
4a9jA-3e4wA:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3egw RESPIRATORY NITRATE
REDUCTASE 1 ALPHA
CHAIN


(Escherichia
coli)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
PF14710
(Nitr_red_alph_N)
4 VAL A 769
LEU A 786
LEU A 771
ILE A 829
None
None
MD1  A1245 (-4.2A)
None
0.90A 4a9jA-3egwA:
undetectable
4a9jA-3egwA:
7.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fcp L-ALA-D/L-GLU
EPIMERASE, A
MUCONATE LACTONIZING
ENZYME


(Klebsiella
pneumoniae)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
4 VAL A 253
LEU A 287
LEU A 273
ILE A 296
None
0.96A 4a9jA-3fcpA:
undetectable
4a9jA-3fcpA:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fhc ATP-DEPENDENT RNA
HELICASE DDX19B


(Homo sapiens)
PF00270
(DEAD)
4 VAL B 288
LEU B 241
LEU B 272
ILE B 248
None
0.97A 4a9jA-3fhcB:
undetectable
4a9jA-3fhcB:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k2k PUTATIVE
CARBOXYPEPTIDASE


(Burkholderia
mallei)
PF00246
(Peptidase_M14)
4 VAL A 212
LEU A 148
LEU A 137
ILE A 256
None
0.84A 4a9jA-3k2kA:
undetectable
4a9jA-3k2kA:
18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k8i 30KLP

(Treponema
pallidum)
no annotation 4 VAL A 187
LEU A  48
LEU A 189
ILE A 277
None
0.88A 4a9jA-3k8iA:
undetectable
4a9jA-3k8iA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lq1 2-SUCCINYL-5-ENOLPYR
UVYL-6-HYDROXY-3-CYC
LOHEXENE-1-CARBOXYLA
TE SYNTHASE


(Listeria
monocytogenes)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
PF16582
(TPP_enzyme_M_2)
4 VAL A  75
LEU A 104
LEU A  77
ILE A  16
None
0.81A 4a9jA-3lq1A:
undetectable
4a9jA-3lq1A:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oc6 6-PHOSPHOGLUCONOLACT
ONASE


(Mycolicibacterium
smegmatis)
PF01182
(Glucosamine_iso)
4 VAL A  54
LEU A  51
LEU A  50
ILE A  39
None
0.90A 4a9jA-3oc6A:
undetectable
4a9jA-3oc6A:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oc6 6-PHOSPHOGLUCONOLACT
ONASE


(Mycolicibacterium
smegmatis)
PF01182
(Glucosamine_iso)
4 VAL A  54
LEU A  92
LEU A  51
ILE A  39
None
0.94A 4a9jA-3oc6A:
undetectable
4a9jA-3oc6A:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oep PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA0988


(Thermus
thermophilus)
PF02626
(CT_A_B)
PF02682
(CT_C_D)
4 VAL A 445
LEU A 408
LEU A 394
ILE A 489
None
0.95A 4a9jA-3oepA:
undetectable
4a9jA-3oepA:
12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pr6 TRAPP-ASSOCIATED
PROTEIN TCA17


(Saccharomyces
cerevisiae)
PF04628
(Sedlin_N)
4 VAL A   8
LEU A  10
LEU A  19
ILE A 115
None
0.94A 4a9jA-3pr6A:
undetectable
4a9jA-3pr6A:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3psh PROTEIN HI_1472

(Haemophilus
influenzae)
PF01497
(Peripla_BP_2)
4 VAL A 251
LEU A 248
LEU A 214
ILE A 272
None
0.89A 4a9jA-3pshA:
undetectable
4a9jA-3pshA:
17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rr1 PUTATIVE
D-GALACTONATE
DEHYDRATASE


(Ralstonia
pickettii)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
4 VAL A 102
LEU A 105
LEU A 106
ILE A  60
None
0.96A 4a9jA-3rr1A:
undetectable
4a9jA-3rr1A:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsn 4-HYDROXYTHREONINE-4
-PHOSPHATE
DEHYDROGENASE


(Campylobacter
jejuni)
PF04166
(PdxA)
4 VAL A  20
LEU A  52
LEU A  45
ILE A  36
None
0.92A 4a9jA-3tsnA:
undetectable
4a9jA-3tsnA:
15.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ttl POLYAMINE TRANSPORT
PROTEIN


(Pseudomonas
aeruginosa)
PF13416
(SBP_bac_8)
4 VAL A 128
LEU A  98
LEU A 103
ILE A  78
None
0.83A 4a9jA-3ttlA:
undetectable
4a9jA-3ttlA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zgk AVR3A11

(Phytophthora
capsici)
PF16810
(RXLR)
4 VAL A  75
LEU A 110
LEU A 106
ILE A  82
None
0.87A 4a9jA-3zgkA:
undetectable
4a9jA-3zgkA:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b6j PHOSPHOSERINE
PHOSPHATASE


(Thermococcus
onnurineus)
PF12710
(HAD)
4 VAL A 168
LEU A 185
LEU A 182
ILE A   7
None
0.98A 4a9jA-4b6jA:
undetectable
4a9jA-4b6jA:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b6z FAMILY M14
UNASSIGNED PEPTIDASE


(Burkholderia
cenocepacia)
PF00246
(Peptidase_M14)
4 VAL A 212
LEU A 148
LEU A 137
ILE A 256
None
0.82A 4a9jA-4b6zA:
undetectable
4a9jA-4b6zA:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fbq DNA REPAIR AND
TELOMERE MAINTENANCE
PROTEIN NBS1,DNA
REPAIR PROTEIN RAD32
CHIMERIC PROTEIN


(Schizosaccharomyces
pombe)
PF00149
(Metallophos)
PF04152
(Mre11_DNA_bind)
4 VAL A1127
LEU A1084
LEU A1049
ILE A1066
None
0.83A 4a9jA-4fbqA:
undetectable
4a9jA-4fbqA:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fcx DNA REPAIR PROTEIN
RAD32


(Schizosaccharomyces
pombe)
no annotation 4 VAL B 127
LEU B  84
LEU B  49
ILE B  66
None
0.82A 4a9jA-4fcxB:
undetectable
4a9jA-4fcxB:
15.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fmz INTERNALIN

(Listeria
monocytogenes)
PF12354
(Internalin_N)
PF12799
(LRR_4)
PF13855
(LRR_8)
4 VAL A 294
LEU A 281
LEU A 303
ILE A 288
None
0.93A 4a9jA-4fmzA:
undetectable
4a9jA-4fmzA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fva 5'-TYROSYL-DNA
PHOSPHODIESTERASE


(Caenorhabditis
elegans)
PF03372
(Exo_endo_phos)
4 VAL A 146
LEU A 154
LEU A 190
ILE A 127
None
0.92A 4a9jA-4fvaA:
undetectable
4a9jA-4fvaA:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE


(Saccharomyces
cerevisiae)
PF07992
(Pyr_redox_2)
4 VAL A 147
LEU A 157
LEU A 159
ILE A 167
VAL  A 147 ( 0.6A)
LEU  A 157 ( 0.6A)
LEU  A 159 ( 0.6A)
ILE  A 167 ( 0.7A)
0.82A 4a9jA-4g9kA:
undetectable
4a9jA-4g9kA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gew 5'-TYROSYL-DNA
PHOSPHODIESTERASE


(Caenorhabditis
elegans)
PF03372
(Exo_endo_phos)
PF14555
(UBA_4)
4 VAL A 146
LEU A 154
LEU A 190
ILE A 127
None
0.94A 4a9jA-4gewA:
undetectable
4a9jA-4gewA:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4glx DNA LIGASE

(Escherichia
coli)
PF01653
(DNA_ligase_aden)
PF03119
(DNA_ligase_ZBD)
PF03120
(DNA_ligase_OB)
PF12826
(HHH_2)
PF14520
(HHH_5)
4 VAL A 444
LEU A 474
LEU A 500
ILE A 458
None
0.76A 4a9jA-4glxA:
undetectable
4a9jA-4glxA:
13.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hbx BROMODOMAIN-CONTAINI
NG PROTEIN 4


(Homo sapiens)
PF00439
(Bromodomain)
5 VAL A  87
LEU A  92
LEU A  94
ASN A 140
ILE A 146
14X  A 201 (-4.7A)
14X  A 201 (-4.4A)
None
14X  A 201 (-3.1A)
14X  A 201 ( 4.0A)
0.38A 4a9jA-4hbxA:
20.5
4a9jA-4hbxA:
70.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hhr ALPHA-DIOXYGENASE

(Arabidopsis
thaliana)
PF03098
(An_peroxidase)
4 VAL A 477
LEU A 482
LEU A 479
ASN A 267
None
HEM  A 701 (-4.5A)
HEM  A 701 (-4.5A)
HEM  A 701 ( 3.4A)
0.93A 4a9jA-4hhrA:
2.8
4a9jA-4hhrA:
12.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hse CHAPERONE PROTEIN
CLPB


(Thermus
thermophilus)
PF00004
(AAA)
4 VAL A 254
LEU A 251
LEU A 237
ILE A 269
None
0.98A 4a9jA-4hseA:
2.3
4a9jA-4hseA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i0o PROTEIN ELYS

(Mus musculus)
PF16687
(ELYS-bb)
4 VAL A 197
LEU A 211
LEU A 152
ILE A 193
None
0.98A 4a9jA-4i0oA:
undetectable
4a9jA-4i0oA:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k0e HEAVY METAL CATION
TRICOMPONENT EFFLUX
PUMP ZNEA(CZCA-LIKE)


(Cupriavidus
metallidurans)
PF00873
(ACR_tran)
4 VAL A  50
LEU A  92
LEU A  90
ASN A 597
None
0.95A 4a9jA-4k0eA:
2.1
4a9jA-4k0eA:
9.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qpc 10-FORMYLTETRAHYDROF
OLATE DEHYDROGENASE


(Danio rerio)
PF00551
(Formyl_trans_N)
PF02911
(Formyl_trans_C)
4 VAL A 290
LEU A 280
LEU A 288
ILE A 211
None
0.95A 4a9jA-4qpcA:
undetectable
4a9jA-4qpcA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tkm NADH-DEPENDENT
REDUCTASE FOR
4-DEOXY-L-ERYTHRO-5-
HEXOSEULOSE URONATE


(Sphingomonas
sp. A1)
PF13561
(adh_short_C2)
4 VAL A  76
LEU A  11
LEU A  89
ILE A  66
None
0.86A 4a9jA-4tkmA:
undetectable
4a9jA-4tkmA:
17.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4uyd BROMODOMAIN-CONTAINI
NG PROTEIN 4


(Homo sapiens)
PF00439
(Bromodomain)
5 VAL A  87
LEU A  92
LEU A  94
ASN A 140
ILE A 146
V1T  A1171 (-4.9A)
V1T  A1171 (-3.8A)
None
V1T  A1171 (-3.1A)
DMS  A1169 ( 4.3A)
0.38A 4a9jA-4uydA:
20.5
4a9jA-4uydA:
71.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4uyg BROMODOMAIN-CONTAINI
NG PROTEIN 2


(Homo sapiens)
PF00439
(Bromodomain)
4 VAL A 376
LEU A 381
LEU A 383
ASN A 429
73B  A1456 (-4.0A)
73B  A1456 (-4.9A)
73B  A1456 (-4.9A)
73B  A1456 (-3.3A)
0.34A 4a9jA-4uygA:
19.3
4a9jA-4uygA:
48.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w8j PESTICIDAL CRYSTAL
PROTEIN CRY1AC


(Bacillus
thuringiensis)
PF00555
(Endotoxin_M)
PF03944
(Endotoxin_C)
PF03945
(Endotoxin_N)
4 VAL A 160
LEU A 148
LEU A 157
ILE A  97
None
0.83A 4a9jA-4w8jA:
2.8
4a9jA-4w8jA:
10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xzg HELICASE-LIKE
TRANSCRIPTION FACTOR


(Homo sapiens)
PF08797
(HIRAN)
4 VAL A 160
LEU A 164
LEU A 171
ILE A 130
None
0.95A 4a9jA-4xzgA:
undetectable
4a9jA-4xzgA:
26.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4z93 BROMODOMAIN-CONTAINI
NG PROTEIN 4


(Homo sapiens)
PF00439
(Bromodomain)
4 VAL A 380
LEU A 385
LEU A 387
ASN A 433
4LD  A 501 ( 3.8A)
4LD  A 501 (-4.1A)
4LD  A 501 (-4.4A)
4LD  A 501 (-2.8A)
0.24A 4a9jA-4z93A:
19.1
4a9jA-4z93A:
37.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zke SUPERKILLER PROTEIN
7


(Saccharomyces
cerevisiae)
PF00009
(GTP_EFTU)
4 VAL A 708
LEU A 687
LEU A 674
ILE A 659
VAL  A 708 ( 0.6A)
LEU  A 687 ( 0.6A)
LEU  A 674 ( 0.6A)
ILE  A 659 ( 0.7A)
0.78A 4a9jA-4zkeA:
undetectable
4a9jA-4zkeA:
15.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hjc BROMODOMAIN-CONTAINI
NG PROTEIN 3


(Homo sapiens)
PF00439
(Bromodomain)
4 VAL A 338
LEU A 343
LEU A 345
ASN A 391
None
0.34A 4a9jA-5hjcA:
19.2
4a9jA-5hjcA:
37.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hqb ALPHA-GLUCOSIDASE

(Pseudoalteromonas
sp. K8)
PF10566
(Glyco_hydro_97)
PF14508
(GH97_N)
PF14509
(GH97_C)
4 VAL A 657
LEU A 621
LEU A 624
ILE A 675
None
0.89A 4a9jA-5hqbA:
undetectable
4a9jA-5hqbA:
13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5huu ALPHA,ALPHA-TREHALOS
E-PHOSPHATE SYNTHASE
[UDP-FORMING]


(Candida
albicans)
PF00982
(Glyco_transf_20)
4 VAL A   9
LEU A 146
LEU A 149
ILE A  78
None
0.85A 4a9jA-5huuA:
undetectable
4a9jA-5huuA:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hxd PROTEIN MPAA

(Escherichia
coli)
PF00246
(Peptidase_M14)
4 VAL A   3
LEU A  70
LEU A  66
ASN A 229
None
0.97A 4a9jA-5hxdA:
undetectable
4a9jA-5hxdA:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hxg UNCHARACTERIZED
PROTEIN STM1697


(Salmonella
enterica)
PF00563
(EAL)
4 VAL A 101
LEU A  95
LEU A  56
ILE A  77
None
0.97A 4a9jA-5hxgA:
undetectable
4a9jA-5hxgA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ido 3' TERMINAL URIDYLYL
TRANSFERASE


(Trypanosoma
brucei)
PF03828
(PAP_assoc)
4 VAL A 283
LEU A 280
LEU A 467
ILE A 362
None
0.96A 4a9jA-5idoA:
undetectable
4a9jA-5idoA:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lc5 NADH DEHYDROGENASE
[UBIQUINONE]
IRON-SULFUR PROTEIN
2, MITOCHONDRIAL


(Bos taurus)
PF00346
(Complex1_49kDa)
4 VAL D 184
LEU D 207
LEU D 203
ILE D 144
None
0.74A 4a9jA-5lc5D:
undetectable
4a9jA-5lc5D:
16.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n15 BROMODOMAIN-CONTAINI
NG FACTOR 1


(Candida
albicans)
PF00439
(Bromodomain)
4 VAL A 238
LEU A 243
ASN A 291
ILE A 297
None
None
IOD  A 404 (-3.9A)
IOD  A 404 ( 4.8A)
0.41A 4a9jA-5n15A:
16.9
4a9jA-5n15A:
31.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nn8 LYSOSOMAL
ALPHA-GLUCOSIDASE


(Homo sapiens)
no annotation 4 VAL A 939
LEU A 941
LEU A 901
ILE A 885
CSO  A 938 ( 2.8A)
None
None
None
0.90A 4a9jA-5nn8A:
undetectable
4a9jA-5nn8A:
10.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nph HEAVY CHAIN OF FAB
FRAGMENT DERIVED
FROM
NON-NEUTRALIZING
ANTIBODY DAO5


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 VAL H 116
LEU H  18
LEU H  86
ILE H  81
None
0.90A 4a9jA-5nphH:
undetectable
4a9jA-5nphH:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5npi SINGLE CHAIN
VARIABLE FRAGMENT OF
THE NON-NEUTRALIZING
ANTIBODY DAO5


(Mus musculus)
PF07686
(V-set)
4 VAL A 116
LEU A  18
LEU A  86
ILE A  81
None
0.85A 4a9jA-5npiA:
undetectable
4a9jA-5npiA:
15.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nxk SERINE-RICH SECRETED
CELL WALL ANCHORED
(LPXTG-MOTIF )
PROTEIN


(Lactobacillus
reuteri)
no annotation 4 VAL A 534
LEU A 536
LEU A 562
ILE A 526
None
0.94A 4a9jA-5nxkA:
undetectable
4a9jA-5nxkA:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5opt RIBOSOMAL PROTEIN
S7, PUTATIVE


(Trypanosoma
cruzi)
no annotation 4 VAL Q  76
LEU Q  83
LEU Q  98
ASN Q  49
None
0.77A 4a9jA-5optQ:
undetectable
4a9jA-5optQ:
21.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5u6v BROMODOMAIN-CONTAINI
NG PROTEIN 2


(Homo sapiens)
no annotation 4 VAL A 376
LEU A 381
LEU A 383
ASN A 429
7WY  A 501 ( 4.5A)
7WY  A 501 (-4.9A)
None
7WY  A 501 (-3.4A)
0.39A 4a9jA-5u6vA:
19.2
4a9jA-5u6vA:
39.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u9n BROMO DOMAIN
CONTAINING PROTEIN


(Cryptosporidium
parvum)
PF00439
(Bromodomain)
4 VAL A 332
LEU A 338
ASN A 413
ILE A 422
BMF  A 501 (-4.2A)
BMF  A 501 ( 4.9A)
BMF  A 501 (-2.8A)
BMF  A 501 ( 4.4A)
0.84A 4a9jA-5u9nA:
15.4
4a9jA-5u9nA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uj8 ORIGIN RECOGNITION
COMPLEX SUBUNIT 3


(Homo sapiens)
PF07034
(ORC3_N)
4 VAL A 288
LEU A 292
LEU A 293
ILE A 325
None
0.97A 4a9jA-5uj8A:
undetectable
4a9jA-5uj8A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v6b PDZ
DOMAIN-CONTAINING
PROTEIN GIPC1


(Mus musculus)
PF00595
(PDZ)
4 VAL A 134
LEU A 209
LEU A 211
ILE A 166
None
0.84A 4a9jA-5v6bA:
undetectable
4a9jA-5v6bA:
18.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vbr BROMODOMAIN
TESTIS-SPECIFIC
PROTEIN


(Homo sapiens)
no annotation 5 VAL A  56
LEU A  61
LEU A  63
ASN A 109
ILE A 115
IBI  A 201 ( 4.6A)
IBI  A 201 (-4.2A)
IBI  A 201 (-4.9A)
IBI  A 201 (-3.3A)
IBI  A 201 ( 3.8A)
0.76A 4a9jA-5vbrA:
20.2
4a9jA-5vbrA:
55.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xog RNA POLYMERASE II
THIRD LARGEST
SUBUNIT B44, PART OF
CENTRAL CORE


(Komagataella
phaffii)
PF01000
(RNA_pol_A_bac)
PF01193
(RNA_pol_L)
4 VAL C   7
LEU C  21
LEU C  19
ILE C 248
None
0.94A 4a9jA-5xogC:
undetectable
4a9jA-5xogC:
16.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zln TOLL-LIKE RECEPTOR 9

(Mus musculus)
no annotation 4 VAL A 420
LEU A 398
LEU A 422
ILE A 410
None
0.97A 4a9jA-5zlnA:
undetectable
4a9jA-5zlnA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ams BETA SLIDING CLAMP

(Pseudomonas
aeruginosa)
no annotation 4 VAL A  37
LEU A  42
LEU A  59
ILE A  90
None
0.93A 4a9jA-6amsA:
undetectable
4a9jA-6amsA:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cw0 CGD2_2690 PROTEIN

(Cryptosporidium
parvum)
no annotation 4 VAL A  30
LEU A  35
LEU A  37
ASN A  83
R78  A 201 (-4.5A)
R78  A 201 (-4.9A)
None
R78  A 201 (-3.3A)
0.64A 4a9jA-6cw0A:
17.5
4a9jA-6cw0A:
23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dne BROMODOMAIN-CONTAINI
NG PROTEIN 4


(Homo sapiens)
no annotation 5 VAL A  87
LEU A  92
LEU A  94
ASN A 140
ILE A 146
H1V  A 501 ( 4.4A)
H1V  A 501 (-4.2A)
H1V  A 501 (-4.7A)
H1V  A 501 (-3.2A)
H1V  A 501 (-3.8A)
0.49A 4a9jA-6dneA:
20.0
4a9jA-6dneA:
undetectable